Abstract
Although the Code of Federal Regulations (21 CFR 312.21) defines phase II studies as “controlled clinical studies,” the vast majority of phase II oncology trials have been single-arm investigations. Granted, a liberal definition of the word “controlled” would allow the use of historical
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have